Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (42) 42
life sciences & biomedicine (40) 40
humans (36) 36
infectious diseases (35) 35
hiv infections - drug therapy (30) 30
female (28) 28
male (27) 27
adult (22) 22
immunology (21) 21
microbiology (21) 21
biological and medical sciences (17) 17
medical sciences (17) 17
viral load (16) 16
hiv (15) 15
middle aged (15) 15
pharmacology & pharmacy (15) 15
antiviral agents (14) 14
life sciences (14) 14
pharmacology. drug treatments (14) 14
virology (12) 12
anti-hiv agents - therapeutic use (11) 11
antibiotics. antiinfectious agents. antiparasitic agents (11) 11
hiv infection (11) 11
hiv infections - virology (11) 11
human immunodeficiency virus--hiv (11) 11
viral diseases (11) 11
human viral diseases (10) 10
treatment outcome (10) 10
adolescent (9) 9
anti-hiv agents - administration & dosage (9) 9
nevirapine (9) 9
viral diseases of the lymphoid tissue and the blood. aids (9) 9
aids (8) 8
aids/hiv (8) 8
antiretroviral drugs (8) 8
cd4 lymphocyte count (8) 8
follow-up studies (8) 8
hiv-1 (8) 8
human health and pathology (8) 8
nevirapine - therapeutic use (8) 8
young adult (8) 8
aged (7) 7
antiretroviral therapy (7) 7
antiretroviral therapy, highly active (7) 7
antiretroviral therapy, highly active - methods (7) 7
immunodeficiencies (7) 7
immunodeficiencies. immunoglobulinopathies (7) 7
immunopathology (7) 7
prospective studies (7) 7
reverse transcriptase inhibitors - therapeutic use (7) 7
risk factors (7) 7
anti-hiv agents - adverse effects (6) 6
france (6) 6
hiv infections - blood (6) 6
hiv/aids (6) 6
infant (6) 6
pregnancy (6) 6
retrospective studies (6) 6
rna, viral - blood (6) 6
virus diseases (6) 6
analysis (5) 5
child (5) 5
children (5) 5
cohort studies (5) 5
dosage and administration (5) 5
drug therapy (5) 5
highly active antiretroviral therapy (5) 5
hiv infections - prevention & control (5) 5
hiv patients (5) 5
pregnancy complications, infectious - drug therapy (5) 5
anti-hiv agents - pharmacokinetics (4) 4
antiretrovirals (4) 4
care and treatment (4) 4
child, preschool (4) 4
confidence intervals (4) 4
disease transmission (4) 4
hiv infections - immunology (4) 4
hiv infections - transmission (4) 4
hiv-1 - isolation & purification (4) 4
infant, newborn (4) 4
infants (4) 4
infectious disease transmission, vertical - prevention & control (4) 4
nevirapine - administration & dosage (4) 4
pharmacology (4) 4
santĂ© publique et Ă©pidĂ©miologie (4) 4
viruses (4) 4
[sdv.mhep]life sciences [q-bio]/human health and pathology (3) 3
[sdv.spee]life sciences [q-bio]/santĂ© publique et Ă©pidĂ©miologie (3) 3
[sdv]life sciences [q-bio] (3) 3
adults (3) 3
aged, 80 and over (3) 3
anti-hiv agents (3) 3
clinical trials (3) 3
cross-sectional studies (3) 3
drug administration schedule (3) 3
drug therapy, combination (3) 3
france - epidemiology (3) 3
hiv 1 (3) 3
hiv infections (3) 3
hiv infections - epidemiology (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Rilpivirine in HIV-1-positive women initiating pregnancy: to switch or not to switch?
by Frange, Pierre and Tubiana, Roland and Sibiude, Jeanne and Canestri, Ana and Arvieux, CĂ©dric and Brunet-Cartier, CĂ©cile and Cotte, Laurent and Reynes, Jacques and Mandelbrot, Laurent and Warszawski, Josiane and Le Chenadec, JĂ©rĂ´me and ANRS EPF CO1 CO11 Study Grp and ANRS EPF CO1/CO11 Study Group
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 05/2020, Volume 75, Issue 5, pp. 1324 - 1331
Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Index Medicus | Life Sciences | Human health and pathology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Is Intrapartum Intravenous Zidovudine for Prevention of Mother-to-Child HIV-1 Transmission Still Useful in the Combination Antiretroviral Therapy Era?
by Nelly Briand and Josiane Warszawski and Laurent Mandelbrot and Catherine Dollfus and Emmanuelle Pannier and Ludovic Cravello and Rose Nguyen and Isabelle Matheron and Norbert Winer and Roland Tubiana and Christine Rouzioux and Albert Faye and Stéphane Blanche and ANRS-EPF CO1-CO11 Study Grp and ANRS-EPF CO1-CO11 Study Group
Clinical infectious diseases, ISSN 1058-4838, 9/2013, Volume 57, Issue 6, pp. 903 - 914
Pregnancy | HIV/AIDS | Antiretrovirals | Disease transmission | HIV | Infants | Viral load | Carts | Cesarean section | HIV 1 | Assisted reproductive techniques | toxicity | zidovudine | mother-to-child HIV transmission | intrapartum prophylaxis | pregnancy | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Antiviral agents | Immunopathology | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Immunodeficiencies. Immunoglobulinopathies | Immunodeficiencies | Antibiotics. Antiinfectious agents. Antiparasitic agents | HIV Infections - prevention & control | Prospective Studies | Pregnancy Complications, Infectious - epidemiology | HIV Infections - epidemiology | Humans | Risk Factors | Male | Antibiotic Prophylaxis | Chi-Square Distribution | Viral Load | Pregnancy Complications, Infectious - drug therapy | Pregnancy Complications, Infectious - prevention & control | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | HIV Infections - transmission | Zidovudine - therapeutic use | Infectious Disease Transmission, Vertical - statistics & numerical data | Infectious Disease Transmission, Vertical - prevention & control | Infant, Newborn | Prevention | Dosage and administration | HIV (Viruses) | Drug therapy | Zidovudine | Health aspects | Antiretroviral drugs | Maternal & child health | Human immunodeficiency virus--HIV | Virology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text In Utero Exposure to Zidovudine and Heart Anomalies in the ANRS French Perinatal Cohort and the Nested PRIMEVA Randomized Trial
by Jeanne Sibiude and Jérôme Le Chenadec and Damien Bonnet and Roland Tubiana and Albert Faye and Catherine Dollfus and Laurent Mandelbrot and Sandrine Delmas and Nathalie Lelong and Babak Khoshnood and Josiane Warszawski and Stéphane Blanche and French Natl Agcy Res AIDS Viral He and French National Agency for Research on AIDS and Viral Hepatitis French Perinatal Cohort/Protease Inhibitor Monotherapy Evaluation Trial
Clinical infectious diseases, ISSN 1058-4838, 7/2015, Volume 61, Issue 2, pp. 270 - 280
HIV/AIDS | PMTCT | zidovudine | heart function | randomized trial | congenital heart defects | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | HIV Infections - prevention & control | Heart Septal Defects, Ventricular - epidemiology | Lamivudine - administration & dosage | Pregnancy Complications, Infectious - virology | Follow-Up Studies | Heart Defects, Congenital - etiology | Humans | Infant | Male | Pregnancy Trimester, First | Zidovudine - administration & dosage | Lamivudine - adverse effects | Young Adult | Uterus | Heart Septal Defects, Ventricular - etiology | Heart Septal Defects, Ventricular - diagnosis | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - transmission | France | Echocardiography | Zidovudine - adverse effects | Anti-HIV Agents - adverse effects | Pregnancy | Pregnancy Complications, Infectious - drug therapy | Sex Factors | Heart Defects, Congenital - epidemiology | HIV Infections - drug therapy | Heart Defects, Congenital - diagnosis | Zidovudine - therapeutic use | Infectious Disease Transmission, Vertical - prevention & control | Drug Combinations | Prevention | Usage | Maternal health services | Disease transmission | Clinical trials | Dosage and administration | Management | Drug therapy | HIV infection | Zidovudine | Risk factors | Heart | Confidence intervals | Antiretroviral drugs | Congenital diseases | Prenatal development | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Risk of birth defects and perinatal outcomes in HIV-infected women exposed to integrase strand inhibitors during pregnancy
by Sibiude, Jeanne and Le Chenadec, JĂ©rĂ´me and Mandelbrot, Laurent and Dollfus, Catherine and Matheron, Sophie and Lelong, Nathalie and Avettand-Fenoel, VĂ©ronique and Brossard, Maud and Frange, Pierre and Reliquet, VĂ©ronique and Warszawski, Josiane and Tubiana, Roland and EPF study group
AIDS (London), ISSN 0269-9370, 10/2020, Volume 35, Issue 2, pp. 219 - 226
Index Medicus | AIDS/HIV
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Dolutegravir and lamivudine maintenance therapy in HIV-1 virologically suppressed patients: results of the ANRS 167 trial (LAMIDOL)
by Joly, Véronique and Burdet, Charles and Landman, Roland and Vigan, Marie and Charpentier, Charlotte and Katlama, Christine and Cabié, André and Benalycherif, Aida and Peytavin, Gilles and Yeni, Patrick and Mentre, France and Argoud, Anne-Laure and Amri, Imane and Descamps, Diane and Yazdanpanah, Yazdan and LAMIDOL Study Grp and LAMIDOL Study Group
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 03/2019, Volume 74, Issue 3, pp. 739 - 745
Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Index Medicus | Life Sciences | Human health and pathology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Dolutegravir Monotherapy Versus Dolutegravir/Abacavir/Lamivudine for Virologically Suppressed People Living With Chronic Human Immunodeficiency Virus Infection: The Randomized Noninferiority MONotherapy of TiviCAY Trial
by Hocqueloux, Laurent and Raffi, François and Prazuck, Thierry and Bernard, Louis and Sunder, Simon and Esnault, Jean-Luc and Rey, David and Le Moal, Gwenaël and Roncato-Saberan, Mariam and André, Marie and Billaud, Eric and Valéry, Antoine and Avettand-Fènoël, Véronique and Parienti, Jean-Jacques and Allavena, Clotilde and MONCAY Study Grp and MONCAY study group
Clinical infectious diseases, ISSN 1058-4838, 10/2019, Volume 69, Issue 9, pp. 1498 - 1505
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Immediate Versus Deferred Switching From a Boosted Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ≥50 Years: Final 96-Week Results of the NEAT022 Study
by Gatell, JosĂ© M and Assoumou, Lambert and Moyle, Graeme and Waters, Laura and Johnson, Margaret and Domingo, Pere and Fox, Julie and Martinez, Esteban and Stellbrink, Hans-JĂ¼rgen and Guaraldi, Giovanni and Masia, Mar and Gompels, Mark and De Wit, Stephane and Florence, Eric and Esser, Stefan and Raffi, François and Stephan, Christoph and Rockstroh, Juergen and Giacomelli, Andrea and Vera, Jaime and Bernardino, JosĂ© Ignacio and Winston, Alan and Saumoy, Maria and Gras, Julien and Katlama, Christine and Pozniak, Anton L and European Network AIDS Treatment and European Network for AIDS Treatment 022 (NEAT022) Study Group
Clinical infectious diseases, ISSN 1058-4838, 02/2019, Volume 68, Issue 4, pp. 597 - 606
Lipids | HIV | Protease inhibitors | Cholesterol | Dolutegravir | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | HIV Protease Inhibitors - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Treatment Outcome | Drug Substitution - methods | HIV Protease Inhibitors - administration & dosage | HIV Integrase Inhibitors - administration & dosage | Drug-Related Side Effects and Adverse Reactions - epidemiology | Drug-Related Side Effects and Adverse Reactions - pathology | Young Adult | HIV Integrase Inhibitors - adverse effects | Heterocyclic Compounds, 3-Ring - administration & dosage | Heterocyclic Compounds, 3-Ring - adverse effects | Lipids - blood | Adolescent | Aged, 80 and over | Adult | Female | HIV Infections - drug therapy | Aged | Antiretroviral Therapy, Highly Active - methods | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text T-Cell Receptor Excision Circles in HIV-Exposed, Uninfected Newborns Measured During a National Newborn Screening Program for Severe Combined Immunodeficiency
by Warszawski, Josiane and Thomas, Caroline and Dialla, Olivia and Garrait, Valérie and Dollfus, Catherine and Reliquet, Veronique and Clech, Laure and Dert, Cécile and Mandelbrot, Laurent and Audrain, Marie and Blanche, Stéphane and Mandelbrot, Laurent and Crenn-Hebert, Catherine and Floch-Tudal, Corinne and Mazy, Fabienne and Joras, Marine and Meier, Françoise and Mortier, Emmanuel and Matheron, Sophie and Elaoun, Neila and Allal, Lahcene and Djoubou, Sandrine and Rahli, Djamila and Moine, Agnès Bourgeois and Valentin, Morgane and Garrait, Valérie and Touboul, Claudine and Ratsimbazafy, Lanto and Boiron, Emilie and Elharrar, Brigitte and Blanche, Stéphane and Driessen, Marine and Frange, Pierre and Veber, Florence and Tubiana, Roland and Dommergues, Marc and Shneider, Luminata and Caby, Fabienne and Calin, Ruxandra-Oana and Yangui, Mohamed Amine and Roca, Didier and Todorova, Darina and Blum, Laurent and Chambrin, Véronique and Clech, Laure and Lachassine, Eric and Benoist, Laurence and Jeantils, Vincent and Benbara, Amélie and Carbillon, Lionel and Dollfus, Catherine and Tabone, Marie-Dominique and Courcoux, Mary-France and Kayem, Gilles and Reliquet, Véronique and Brunet-Cartier, Cécile and Winer, Norbert and Vaucel, Edouard and Wack, Thierry and Leymarie, Isabelle and Selmi, Lamya Ait Si and Benali, Fazia ait and Brossard, Maud and ANRS EPF Study Group and ANRS EPF Study Grp
The Journal of pediatrics, ISSN 0022-3476, 11/2018, Volume 202, pp. 311 - 314.e2
newborn | TREC | HIV | T cell | pregnancy | lymphocyte | Life Sciences & Biomedicine | Pediatrics | Science & Technology | Measurement | Infants (Newborn) | Nucleosides | HIV testing | DNA polymerases | T cells | HIV (Viruses) | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Santé publique et épidémiologie
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Influence of nevirapine administration on the pharmacokinetics of dolutegravir in patients infected with HIV-1
by Dailly, Eric and Allavena, Clotilde and Grégoire, Matthieu and Reliquet, Véronique and Bouquié, Régis and Billaud, Eric and Hernando, Hélène and Bouchez, Sabelline and Deslandes, Guillaume and Hall, Nolwenn and Jolliet, Pascale and Raffi, François
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 12/2015, Volume 70, Issue 12, pp. 3307 - 3310
Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Prospective Studies | HIV Infections - virology | Humans | Middle Aged | Male | Anti-HIV Agents - administration & dosage | Drug Interactions | HIV-1 - isolation & purification | Anti-HIV Agents - pharmacokinetics | Adult | Female | HIV Infections - drug therapy | Aged | Heterocyclic Compounds, 3-Ring - pharmacokinetics | Nevirapine - administration & dosage | Prescription drugs | Kinetics | Metabolism | Human immunodeficiency virus--HIV | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Nevirapine-raltegravir combination, an NRTI and PI/r sparing regimen, as maintenance antiretroviral therapy in virologically suppressed HIV-1-infected patients
by Reliquet, Veronique and Chirouze, Catherine and Allavena, Clotilde and Muret, Patrice and Peytavin, Gilles and Andre-Garnier, Elisabeth and Bettinger, Dominique and Ferre, Virginie and Hoen, Bruno and Raffi, Francois
Antiviral therapy, ISSN 1359-6535, 01/2014, Volume 19, Issue 1, pp. 117 - 123
Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Science & Technology | Virology | HIV-1 | Follow-Up Studies | HIV Infections - virology | Humans | Middle Aged | Protease Inhibitors | Risk Factors | Pyrrolidinones - therapeutic use | Male | Nevirapine - therapeutic use | Treatment Outcome | CD4 Lymphocyte Count | Viral Load | Antiretroviral Therapy, Highly Active | HIV Infections - immunology | Female | HIV Infections - drug therapy | Retrospective Studies | Reverse Transcriptase Inhibitors | Drug Substitution | Raltegravir Potassium | Drug Combinations
Journal Article
Details down arrow